-
EP4392063
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4392063
| EP4392063 - ANTIBODIES TARGETING IMMUNOSUPPRESSIVE B CELLS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 31.05.2024 Database last updated on 24.08.2024 | |
| Former | The international publication has been made Status updated on 03.03.2023 | Most recent event Tooltip | 31.05.2024 | Publication in section I.1 EP Bulletin | published on 03.07.2024 [2024/27] | 31.05.2024 | Request for examination filed | published on 03.07.2024 [2024/27] | Applicant(s) | For all designated states Biograph 55, Inc. 455 Mission Bay Boulevard South San Francisco, CA 94158 / US | [2024/27] | Inventor(s) | 01 /
PRESTA, Leonard San Francisco, California 94158 / US | 02 /
TUMEH, Paul San Francisco, California 94158 / US | 03 /
LONBERG, Nils San Francisco, California 94158 / US | 04 /
DURAMAD, Omar San Francisco, California 94158 / US | [2024/27] | Representative(s) | Avidity IP Broers Building Hauser Forum 21 JJ Thomson Avenue Cambridge CB3 0FA / GB | [2024/27] | Application number, filing date | 22862041.5 | 24.08.2022 | [2024/27] | WO2022US41400 | Priority number, date | US202163237065P | 25.08.2021 Original published format: US 202163237065 P | [2024/27] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2023028162 | Date: | 02.03.2023 | Language: | EN | [2023/09] | Type: | A1 Application with search report | No.: | EP4392063 | Date: | 03.07.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 02.03.2023 takes the place of the publication of the European patent application. | [2024/27] | Search report(s) | International search report - published on: | AU | 02.03.2023 | Classification | IPC: | A61K39/00, A61K39/395, A61P35/00, C07K16/28, C07K16/40, C07K16/46 | [2024/27] | CPC: |
A61P35/00 (EP,AU);
C07K16/468 (EP,AU);
A61K39/00 (EP,AU,US);
A61K39/395 (AU);
C07K16/2803 (EP,AU);
C07K16/2896 (EP);
C07K16/40 (AU);
A61K2039/505 (AU);
A61K2039/507 (AU);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/27] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | ANTIKÖRPER GEGEN IMMUNSUPPRESSIVE B-ZELLEN | [2024/27] | English: | ANTIBODIES TARGETING IMMUNOSUPPRESSIVE B CELLS | [2024/27] | French: | ANTICORPS CIBLANT DES LYMPHOCYTES B IMMUNOSUPPRESSEURS | [2024/27] | Entry into regional phase | 27.02.2024 | National basic fee paid | 27.02.2024 | Search fee paid | 27.02.2024 | Designation fee(s) paid | 27.02.2024 | Examination fee paid | Examination procedure | 27.02.2024 | Examination requested [2024/27] |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO2007044616 (XENCOR INC [US], et al); | [A]WO2014145806 (XENCOR INC [US], et al); | [PA]WO2021173844 (BIOGRAPH 55 INC [US]); |